Competitive enzyme-linked immunosorbent assay based on a rhoptry-associated protein 1 epitope specifically identifies Babesia bovis-infected cattle

被引:38
作者
Goff, WL [1 ]
McElwain, TF
Suarez, CE
Johnson, WC
Brown, WC
Norimine, J
Knowles, DP
机构
[1] Washington State Univ, Anim Dis Res Unit, USDA ARS, Pullman, WA 99164 USA
[2] Washington State Univ, Coll Vet Med, Program Vector Borne Dis, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA
关键词
D O I
10.1128/CDLI.10.1.38-43.2003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The competitive enzyme-linked immunosorbent assay (cELISA) format has proven to be an accurate, reliable, easily standardized, and high-throughput method for detecting hemoparasite infections. In the present study, a species-specific, broadly conserved, and tandemly repeated B-cell epitope within the C terminus of the rhoptry-associated protein I of the hemoparasite Babesia bovis was cloned and expressed as a histidine-tagged thioredoxin fusion peptide and used as antigen in a cELISA. The assay was optimized with defined negative and positive bovine sera, where positive sera inhibited the binding of the epitope-specific monoclonal antibody BABB75A4. The cELISA accurately differentiated animals with B. bovis-specific antibodies from uninfected animals and from animals with antibodies against other tick-borne hemoparasites (98.7% specificity). In addition, B. bovis-specific sera from Australia, Argentina, Bolivia, Puerto Rico, and Morocco inhibited the binding of BABB75A4, confirming conservation of the epitope. The assay first detected experimentally infected animals between 13 and 17 days postinfection, and with sera from naturally infected carrier cattle, was comparable to indirect immunofluorescence (98.3% concordance). The assay appears to have the characteristics necessary for an epidemiologic and disease surveillance tool.
引用
收藏
页码:38 / 43
页数:6
相关论文
共 26 条
  • [1] Comparison between enzyme-linked immunosorbent assay, indirect fluorescent antibody and rapid conglutination tests in detecting antibodies against Babesia bovis
    Araujo, FR
    Madruga, CR
    Leal, CRB
    Schenk, MAM
    Kessler, RH
    Marques, APC
    Lemaire, DC
    [J]. VETERINARY PARASITOLOGY, 1998, 74 (2-4) : 101 - 108
  • [2] A MICROPLATE ENZYME-IMMUNOASSAY FOR DETECTING AND MEASURING ANTIBODIES TO BABESIA-BOVIS IN CATTLE SERUM
    BARRY, DN
    RODWELL, BJ
    TIMMS, P
    MCGREGOR, W
    [J]. AUSTRALIAN VETERINARY JOURNAL, 1982, 59 (05) : 136 - 140
  • [3] Detection of cattle naturally infected with Anaplasma marginale in a region of endemicity by nested PCR and a competitive enzyme-linked immunosorbent assay using recombinant major surface protein 5
    de Echaide, ST
    Knowles, DP
    McGuire, TC
    Palmer, GH
    Suarez, CE
    McElwain, TF
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (03) : 777 - 782
  • [4] Figueroa J. V., 1994, Revista Latinoamericana de Microbiologia, V36, P47
  • [5] Babesia bovis immunity -: In vitro and in vivo evidence for IL-10 regulation of IFN-γ and iNOS
    Goff, WL
    Johnson, WC
    Cluff, CW
    [J]. TROPICAL VETERINARY MEDICINE: MOLECULAR EPIDEMIOLOGY, HEMOPARASITES AND THEIR VECTORS, AND GENERAL TOPICS, 1998, 849 : 161 - 180
  • [6] IDENTIFICATION OF BABESIA-BOVIS MEROZOITE SURFACE-ANTIGENS BY USING IMMUNE BOVINE SERA AND MONOCLONAL-ANTIBODIES
    GOFF, WL
    DAVIS, WC
    PALMER, GH
    MCELWAIN, TF
    JOHNSON, WC
    BAILEY, JF
    MCGUIRE, TC
    [J]. INFECTION AND IMMUNITY, 1988, 56 (09) : 2363 - 2368
  • [7] THE BOVINE IMMUNE-RESPONSE TO TICK-DERIVED BABESIA-BOVIS INFECTION - SEROLOGICAL STUDIES OF ISOLATED IMMUNOGLOBULINS
    GOFF, WL
    WAGNER, GG
    CRAIG, TM
    LONG, RF
    [J]. VETERINARY PARASITOLOGY, 1982, 11 (2-3) : 109 - 120
  • [9] JOHNSON WC, 2001, P 10 INT S VET LAB D, P322
  • [10] Detection of equine antibodies to Babesia caballi by recombinant B-caballi rhoptry-associated protein 1 in a competitive-inhibition enzyme-linked immunosorbent assay
    Kappmeyer, LS
    Perryman, LE
    Hines, SA
    Baszler, TV
    Katz, JB
    Hennager, SG
    Knowles, DP
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (07) : 2285 - 2290